Future of field excellence in life sciences: Global pharma & biotech report

How life sciences field teams are evolving 

Healthcare professional expectations are changing, and life sciences organizations are under pressure to rethink how their field teams create value. As traditional engagement models evolve, pharmaceutical and biotech companies need new strategies, capabilities, and operating models to strengthen field impact. 

Inizio Engage’s Future of Field Excellence in Life Sciences Report explores how organizations are responding to these shifts and what it will take to close the gap between ambition and execution. 

Building on insights from our  2024 Field Excellence Report, this new research highlights how leading organizations are evolving their field engagement strategies to better support commercial, medical affairs, and market access teams.  

Research at a glance 

• 100+ life sciences leaders and professionals surveyed  
• 54 pharmaceutical and biotech companies represented  
• Research conducted across EMEA, the US, Canada, APAC, and LATAM 
• Perspectives from commercial, medical affairs, market access, and learning and development leaders  

This global research provides a cross-functional view of how organizations are approaching field excellence in life sciences.  

What you’ll learn in the report 

This report explores the forces reshaping field engagement in pharma and biotech, including:  

• How organizations are redefining field excellence 
• Capabilities needed for modern field teams 
• Barriers preventing field impact 
• Practical recommendations for strengthening field capabilities 

The report also highlights five key trends shaping the future of field engagement across the life sciences industry.

Download the report

Get the report and discover how leading pharma and biotech organizations are strengthening field engagement.